FDA Recommendations Regarding Januvia

In September of 2009, the FDA revised Januvia’s label to reflect the number of reported cases of pancreatitis.  The FDA recommended that doctors carefully monitor their patients for symptoms of the disease after starting a patient on the drug, or after increasing dosage.

They also caution that there has been no research done on the effect of Januvia in patients with a history of pancreatitis.  Therefore if you do have such a history and have been prescribed the drug, you should talk to your doctor before beginning it, or make sure you are monitored carefully while on Januvia.

The FDA also recommends you be particularly thoughtful about taking Januvia if you have ever had the following:

• Pancreatitis
• Gallstones
• A history of alcoholism
• High blood triglyceride levels
• Kidney problems

Have you taken Januvia and suffered pancreatic complications?  If so, the attorneys at Kirkendall Dwyer LLP can help.  Contact us today for a free case review.